Related references
Note: Only part of the references are listed.Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study
L. R. van der Werf et al.
EUROPEAN JOURNAL OF CANCER (2018)
Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival
Kine Mari Bakke et al.
ACTA ONCOLOGICA (2017)
Endoscopic biopsy and EUS for the detection of pathologic complete response after neoadjuvant chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis
Peter S. N. van Rossum et al.
GASTROINTESTINAL ENDOSCOPY (2016)
Apparent diffusion coefficient (ADC) change on repeated diffusion-weighted magnetic resonance imaging during radiochemotherapy for non-small cell lung cancer: A pilot study
Elisabeth Weiss et al.
LUNG CANCER (2016)
Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy
Sophie E. Heethuis et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Using a Machine Learning Approach to Predict Outcomes after Radiosurgery for Cerebral Arteriovenous Malformations
Eric Karl Oermann et al.
SCIENTIFIC REPORTS (2016)
Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer
Martijn Intven et al.
ACTA ONCOLOGICA (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro et al.
LANCET ONCOLOGY (2015)
Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer
Peter S. N. van Rossum et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Multiparametric Magnetic Resonance Imaging for Predicting Pathological Response After the First Cycle of Neoadjuvant Chemotherapy in Breast Cancer
Xia Li et al.
INVESTIGATIVE RADIOLOGY (2014)
Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer
Joel Shapiro et al.
ANNALS OF SURGERY (2014)
Pretreatment Diffusion-Weighted and Dynamic Contrast-Enhanced MRI for Prediction of Local Treatment Response in Squamous Cell Carcinomas of the Head and Neck
Sanjeev Chawla et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2013)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer
Monique Maas et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Can 18F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis
Yu-mei Chen et al.
NUCLEAR MEDICINE COMMUNICATIONS (2011)
Predicting and Monitoring Cancer Treatment Response with Diffusion-Weighted MRI
Harriet C. Thoeny et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
Prediction of Tumor Response to Neoadjuvant Therapy in Patients with Esophageal Cancer with Use of F-18 FDG PET: A Systematic Review
Robert M. Kwee
RADIOLOGY (2010)
Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival
James M. Donahue et al.
ANNALS OF THORACIC SURGERY (2009)
Simultaneous multi-modality ROI delineation in clinical practice
Gijsbert H. Bol et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2009)
Predicting radiotherapy outcomes using statistical learning techniques
Issam El Naqa et al.
PHYSICS IN MEDICINE AND BIOLOGY (2009)
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
[Anonymous]
NEOPLASIA (2009)
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus - Five-year survival of a randomized clinical trial
Jikke M. T. Omloo et al.
ANNALS OF SURGERY (2007)
Diffusion-weighted MRI in the body: Applications and challenges in oncology
Dow-Mu Koh et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2007)
Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy
Mark A. Zahra et al.
LANCET ONCOLOGY (2007)
User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability
Paul A. Yushkevich et al.
NEUROIMAGE (2006)
Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy - Systematic review
M Westerterp et al.
RADIOLOGY (2005)
Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
AC Berger et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation
LR Chirieac et al.
CANCER (2005)
Share Paper
